Merdol Ibrahim

1.2k total citations
19 papers, 735 citations indexed

About

Merdol Ibrahim is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Merdol Ibrahim has authored 19 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Molecular Biology. Recurrent topics in Merdol Ibrahim's work include HER2/EGFR in Cancer Research (14 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Breast Cancer Treatment Studies (4 papers). Merdol Ibrahim is often cited by papers focused on HER2/EGFR in Cancer Research (14 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Breast Cancer Treatment Studies (4 papers). Merdol Ibrahim collaborates with scholars based in United Kingdom, Canada and Australia. Merdol Ibrahim's co-authors include John M.S. Bartlett, Ian O. Ellis, Jane Starczynski, Sarah E. Pinder, Keith Miller, Bharat Jasani, P J Carder, Andrew M. Hanby, S Hales and Emad A. Rakha and has published in prestigious journals such as Journal of Clinical Pathology, American Journal of Clinical Pathology and Journal of Thoracic Oncology.

In The Last Decade

Merdol Ibrahim

19 papers receiving 719 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Merdol Ibrahim United Kingdom	15	469	275	262	254	146	19	735
Sara Ravaioli Italy	16	351 0.7×	330 1.2×	212 0.8×	258 1.0×	439 3.0×	54	939
Svjetlana Mohrmann Germany	16	588 1.3×	441 1.6×	222 0.8×	202 0.8×	236 1.6×	63	1.1k
Cynthia Aparecida Bueno de Toledo Osório Brazil	18	260 0.6×	311 1.1×	178 0.7×	204 0.8×	110 0.8×	49	786
Linda Schiffhauer United States	14	242 0.5×	182 0.7×	145 0.6×	179 0.7×	97 0.7×	30	533
M. Piccart-Gebhart Belgium	7	622 1.3×	588 2.1×	157 0.6×	180 0.7×	121 0.8×	21	956
Sho Shiino Japan	12	247 0.5×	444 1.6×	96 0.4×	372 1.5×	119 0.8×	38	792
Shinobu Masuda Japan	16	496 1.1×	412 1.5×	146 0.6×	220 0.9×	242 1.7×	88	933
Tammy Piper United Kingdom	11	470 1.0×	595 2.2×	116 0.4×	238 0.9×	213 1.5×	27	911
Roberto Salgado Belgium	12	555 1.2×	246 0.9×	204 0.8×	222 0.9×	187 1.3×	37	822
Edward Clark United States	6	468 1.0×	279 1.0×	223 0.9×	330 1.3×	85 0.6×	6	764

Countries citing papers authored by Merdol Ibrahim

Since Specialization

Citations

This map shows the geographic impact of Merdol Ibrahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merdol Ibrahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merdol Ibrahim more than expected).

Fields of papers citing papers by Merdol Ibrahim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merdol Ibrahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merdol Ibrahim. The network helps show where Merdol Ibrahim may publish in the future.

Co-authorship network of co-authors of Merdol Ibrahim

This figure shows the co-authorship network connecting the top 25 collaborators of Merdol Ibrahim. A scholar is included among the top collaborators of Merdol Ibrahim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Merdol Ibrahim. Merdol Ibrahim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Dodson, Andrew, Suzanne Parry, Merdol Ibrahim, et al.. (2018). Breast cancer biomarkers in clinical testing: analysis of a UK national external quality assessment scheme for immunocytochemistry and in situ hybridisation database containing results from 199 300 patients. The Journal of Pathology Clinical Research. 4(4). 262–273. 41 indexed citations

Torlakovic, Emina, Carol C. Cheung, Corrado D’Arrigo, et al.. (2017). Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine – Part 2: Immunohistochemistry Test Performance Characteristics. Applied immunohistochemistry & molecular morphology. 25(2). 79–85. 28 indexed citations

Torlakovic, Emina, Carol C. Cheung, Corrado D’Arrigo, et al.. (2017). Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC Laboratories. Applied immunohistochemistry & molecular morphology. 25(3). 151–159. 36 indexed citations

Cheung, Carol C., Corrado D’Arrigo, Manfred Dietel, et al.. (2016). Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1: Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry Biomarkers. Applied immunohistochemistry & molecular morphology. 25(1). 4–11. 30 indexed citations

Cheung, Carol C., Corrado D’Arrigo, Manfred Dietel, et al.. (2016). Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 4: Tissue Tools for Quality Assurance in Immunohistochemistry. Applied immunohistochemistry & molecular morphology. 25(4). 227–230. 18 indexed citations

Ibrahim, Merdol, Suzanne Parry, David W. Allen, et al.. (2016). ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment Regimen. Journal of Thoracic Oncology. 11(12). 2241–2247. 27 indexed citations

Torlakovic, Emina, Søren Nielsen, Glenn Francis, et al.. (2015). Standardization of Positive Controls in Diagnostic Immunohistochemistry:Recommendations From the International Ad Hoc Expert Committee. VBN Forskningsportal (Aalborg Universitet). 6 indexed citations

Torlakovic, Emina, Søren Nielsen, Glenn Francis, et al.. (2014). Standardization of Positive Controls in Diagnostic Immunohistochemistry. Applied immunohistochemistry & molecular morphology. 23(1). 1–18. 66 indexed citations

Rakha, Emad A., Sarah E. Pinder, John M.S. Bartlett, et al.. (2014). Updated UK Recommendations for HER2 assessment in breast cancer. Journal of Clinical Pathology. 68(2). 93–99. 194 indexed citations

10.

Torlakovic, Emina, Glenn Francis, J. R. Garratt, et al.. (2014). Standardization of Negative Controls in Diagnostic Immunohistochemistry. Applied immunohistochemistry & molecular morphology. 22(4). 241–252. 70 indexed citations

11.

Bartlett, J. M. S., Jane Starczynski, Neil Atkey, et al.. (2011). HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods. Journal of Clinical Pathology. 64(8). 649–653. 56 indexed citations

12.

Bartlett, John M.S., Fiona Campbell, Merdol Ibrahim, et al.. (2010). A UK NEQAS ISH Multicenter Ring Study Using the Ventana HER2 Dual-Color ISH Assay. American Journal of Clinical Pathology. 135(1). 157–162. 32 indexed citations

13.

Bartlett, John M.S., Fiona Campbell, Merdol Ibrahim, et al.. (2010). A UK NEQAS ICC and ISH multicentre study using the Kreatech Poseidon HER2 FISH probe: intersite variation can be rigorously controlled using FISH. Histopathology. 56(3). 297–304. 8 indexed citations

14.

Barker, Craig, et al.. (2009). Nondestructive Quality Control of HER2 Control Cell Line Sections. Applied immunohistochemistry & molecular morphology. 17(6). 536–542. 3 indexed citations

15.

Bartlett, John M.S., Fiona Campbell, Merdol Ibrahim, et al.. (2009). Chromogenic In Situ Hybridization. American Journal of Clinical Pathology. 132(4). 514–520. 30 indexed citations

16.

Bartlett, John M.S., Merdol Ibrahim, Bharat Jasani, et al.. (2008). External Quality Assurance of HER2 FISH and ISH Testing. American Journal of Clinical Pathology. 131(1). 106–111. 21 indexed citations

17.

Ibrahim, Merdol, et al.. (2008). Potential for False-Positive Staining With a Rabbit Monoclonal Antibody to Progesterone Receptor (SP2). American Journal of Clinical Pathology. 129(3). 398–409. 29 indexed citations

18.

Miller, Keith, et al.. (2007). Technical aspects of predictive and prognostic markers in breast cancer: What UK NEQAS data shows. Current Diagnostic Pathology. 13(2). 135–149. 8 indexed citations

19.

Bartlett, John M.S., Merdol Ibrahim, Keith Miller, et al.. (2006). External quality assurance of HER2 fluorescence in situ hybridisation testing: results of a UK NEQAS pilot scheme. Journal of Clinical Pathology. 60(7). 816–819. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact